Novartis AG (NVS) Vasella Exit Opens Door to Roche (RHHBY) Stake Sale
5/17/2013 8:21:07 AM
More...
|
Curie-Cancer and Roche (RHHBY) Strengthen Partnership to Fast-Track the Development of New Molecules
5/16/2013 9:57:57 AM
More...
|
New Roche (RHHBY) Award for Antibody-based Cancer Therapy Research
5/16/2013 9:25:23 AM
More...
|
Merck & Co., Inc. (MRK), Bristol-Myers Squibb Company (BMY) and Roche (RHHBY)'s Human Immune-Boosting Cancer Drugs Seen Extending Lives
5/13/2013 7:59:31 AM
More...
|
Guilty Plea Expected in Fake Version of Roche (RHHBY)'s Avastin Case
4/25/2013 7:36:14 AM
More...
|
Roche (RHHBY) Release: Health Canada Approves PERJETA™, a New First-In-Class Targeted Therapy for the Treatment of HER2-Positive Metastatic Breast Cancer(1)
4/23/2013 10:42:39 AM
More...
|
Week in Review: Ascletis, Inc. Collaborates With Roche (RHHBY) on HCV Treatment
4/22/2013 9:24:09 AM
More...
|
Celltrion, Inc. Drops Late-Stage Trial of Roche (RHHBY) Rituxan Drug Copy
4/18/2013 7:56:51 AM
More...
|
Roche (RHHBY), Ascletis, Inc. to Collaborate on Hepatitis C Drugs for China
4/15/2013 8:46:10 AM
More...
|
Roche (RHHBY) and Isis Pharmaceuticals, Inc. (ISIS) Form $392 Million Alliance for Huntington's Disease
4/8/2013 7:57:03 AM
More...
|
|